Lack of Tumors in Infants With Perinatal HIV-1 Exposure and Fetal/Neonatal Exposure to Zidovudine
I. Celine Hanson(Baylor College of Medicine), David E. Shapiro(Intercept Pharmaceuticals (United States)), James M. Oleske(Rutgers, The State University of New Jersey), Mary Culnane(National Institute of Allergy and Infectious Diseases), Leslie A. Kalish(Boston Children's Hospital), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Rhoda Sperling(MDS Associates (United States)), Mary Glenn Fowler(Johns Hopkins University), Tracy A. Antonelli(New England Research Institutes), George McSherry(Rutgers New Jersey Medical School), Ellen Cooper(Boston University), Sophia S. Lee(Harvard University)
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology
April 1, 1999
Cited by 123
Related Papers
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
|Science|1984|3.6k